| Comparison |
Unique Gene Count |
| Article | Gene Count |
Technology | Platform |
|
| Acinar (adjacent to cancer) / Chronic Pancreatitis (CP) (microdissected) | 19 | |
| Acinar (adjacent to cancer) / Normal pancreas NP (microdissected) | 19 | |
| Adenovirus sensitive / resistant (PaTu8988 cell line) | 800 | | Wang Y et al (2009) | 800 | Transcriptomics | oligo Array;Commercial Array Plattform:U133 Plus 2.0 Affymetrix GeneChip; |
|
| Ampullary Carcinoma / Normal duodenum | 190 | | Van Heek NT et al (Jul-04) | 190 | Transcriptomics | oligo Array;Commercial Array Plattform:U133A Affymetrix GeneChip;Commercial Array Plattform:U133B Affymetrix GeneChip; |
|
| Cell line (CL) / Normal pancreas NP (bulk tissue) | 199 | | Logsdon CD et al (May-03) | 98 | Transcriptomics | oligo Array;Commercial Array Plattform:GeneChip HuGeneFL Affymetrix (7000 sequences representing 5600 full-length human genes); | | Szafranska et al (2007) | 101 | miRNA | miRNA-Array(mirVana miRNA Bioarray (Ambion); |
|
| Chronic pancreatitis (CP) / Normal Pancreas (NP) (bulk tissue) (pooled from specimens derived from patients who had benign lesions of the pancreas) | 120 | |
| Chronic pancreatitis (CP) / Normal pancreas ND (adjacent to cancer) | 19 | |
| Chronic pancreatitis (CP) / Normal pancreas NP (bulk tissue) | 996 | |
| Erlotinib, cetuximab sensive / resistant (Xenograft from pancreatic cancer patient (ectopic)) | 24 | | Jimeno A et al (2008) | 24 | Transcriptomics | oligo Array;Commercial Array Plattform:U133 Plus 2.0 Affymetrix GeneChip; |
|
| Fine needle aspirates (FNA) / Normal pancreas NP (bulk tissue) | 28 | |
| gemcitabine sensitive (L3.6pl, BxPC-3, CFPAC-1, SU86.86) / resistant (PANC-1 Hs766T, AsPC-1, MIAPaCa-2, MPanc96) | 90 | |
| Intraductal papillary mucinous neoplasms (IPMN) / HPDE (ductal cell line) | 92 | |
| Intraductal papillary mucinous neoplasms (IPMN) / Normal pancreas ND (microdissected normal ductal cells) | 871 | | Sato A et al (Mar-04) | 871 | Transcriptomics | qRT-PCR;oligo Array;Commercial Array Plattform:U133A Affymetrix GeneChip; |
|
| IPI-504 Treated / untreated (Xenograft from pancreatic cancer patient (ectopic)) | 176 | | Song D et al (Mar-10) | 176 | Transcriptomics | oligo Array;Commercial Array Plattform:U133 Plus 2.0 Affymetrix GeneChip; |
|
| MTX treated sensitive / resistant (MIAPaCa-2) | 1519 | | Selga E et al (2009) | 1519 | Transcriptomics | oligo Array;Commercial Array Plattform:U133 Plus 2.0 Affymetrix GeneChip; |
|
| Mucinous cystic neoplasms (MCN) / Normal Ductal (microdissected) | 28 | |
| Mucinous cystic ovarian type stroma /fibrous stromal cells | 23 | |
| Normal Pancreas (adjacent to cancer) / Normal pancreas NP (bulk tissue) | 1 | |
| Normal pancreas ND (microdissected normal ductal cells) / Normal pancreas NP (bulk tissue) | 1 | |
| Pancreatic Acinar Cell Carcinoma (PACC) / Normal pancreas NP (bulk tissue) | 31 | |
| Pancreatic adenocarcinoma (PDAC) / Cell line (CL) (bulk tissue) | 79 | |
| Pancreatic adenocarcinoma (PDAC) / Chronic pancreatitis (CP) (bulk tissue) | 1078 | |
| Pancreatic adenocarcinoma (PDAC) / Chronic pancreatitis (CP) (microdissected stromal cells) | 99 | | Pilarsky C et al (Dec-08) | 99 | Transcriptomics | oligo Array;Commercial Array Plattform:U133A Affymetrix GeneChip;Commercial Array Plattform:U133B Affymetrix GeneChip; |
|
| Pancreatic adenocarcinoma (PDAC) / Chronic pancreatitis (CP) (miscrodissected) | 18 | |
| Pancreatic adenocarcinoma (PDAC) / Healthy donors (Urine) | 22 | |
| Pancreatic adenocarcinoma (PDAC) / ND or HPDE | 503 | |
| Pancreatic adenocarcinoma (PDAC) / Normal pancreas (normal ductal cells) (both microdissected) | 1076 | |
| Pancreatic adenocarcinoma (PDAC) / Normal pancreas ND (adjacent to cancer) | 26 | |
| Pancreatic adenocarcinoma (PDAC) / Normal pancreas NP (bulk tissue adjacent to cancer) | 8 | |
| Pancreatic adenocarcinoma (PDAC) / Normal pancreas NP (bulk tissue) | 1514 | |
| Pancreatic adenocarcinoma (PDAC) node-positive with at least 24 months survival/ Pancreatic adenocarcinoma (PDAC) dying of disease within 24 months | 5 | |
| Pancreatic cancer (PC) liver metastasis / Normal Pancreas (NP) | 2 | | Esposito I et al (Jan-07) | 1 | Transcriptomics | oligo Array;Commercial Array Plattform: Affymetrix HG U95Av2;IHC; | | Li J et al (Apr-05) | 1 | Transcriptomics | oligo Array;Commercial Array Plattform: Affymetrix HG U95Av2;qRT-PCR;in situ hybridization; |
|
| Pancreatic Cancer / Normal Pancreas (NP) (bulk tissue) | 76 | |
| Pancreatic Cancer Cell line PANC-1 / Pancreatic Cancer Cell line SW1990 | 8 | |
| Pancreatic Cancer Cell lines (Panc-1, MIA PaCa-2,BxPC-3, Hs766T, ASPC-1, Capan-1, Capan-2, Panc3.27, HPAF-II, PL45) / Human Pancreatic Ductal Epithelium cell line (HPDE) | 8 | |
| Pancreatic Cancer Cell lines highly invasive/metastatic (SU86.86;Suit0028;HPAF-II;MPanc96;AsPC-1;PaTu8988S;Suit007) / Pancreatic Cancer Cell lines less invasive/metastatic (Capan-2;PaTu 8902;PaTu8988;PANC-1;BxPC-3;A818;PT45;Capan-1;MIAPaCa-2) | 58 | |
| Pancreatic Cancer patients / Benign pancreatic disease (Chronic pancreatitis and pancreatic pseudocyst) (Serum) | 40 | |
| Pancreatic Cancer patients / non-cancer healthy donors (Plasma) | 9 | |
| Pancreatic cancer/Healthy control (Saliva) | 34 | | Zhang L et al (2010) | 34 | Transcriptomics | oligo Array;Commercial Array Plattform:U133 Plus 2.0 Affymetrix GeneChip; |
|
| Pancreatic cancer/Healthy control (Serum) | 25 | |
| Pancreatic Endocrine Tumors (PETs) (functioning and non-functioning) / Normal pancreas NP (bulk tissue) | 83 | |
| Pancreatic Endocrine Tumors (PETs) (functioning and non-functioning) with liver metastasis / Pancreatic Endocrine Tumors (PETs) (functioning and non-functioning) without liver metastasis | 1 | |
| Pancreatic Endocrine Tumors (PETs) (functioning and non-functioning), High(Ki67>2%) proliferation index/Pancreatic Endocrine Tumors (PETs) (functioning and non-functioning) w/o low(Ki67<=2%) proliferation index | 1 | |
| Pancreatic Endocrine Tumors (PETs) (functioning, insulinomas) / Pancreatic Acinar Cell Carcinoma (PACC) | 10 | |
| Pancreatic Endocrine Tumors (PETs) (functioning, insulinomas) / Pancreatic Endocrine Tumors (PETs) (non-functioning) | 3 | |
| Pancreatic Endocrine Tumors (PETs) (non-functioning) / Islet cells (bulk tissue) | 192 | |
| Pancreatic Endocrine Tumors (PETs) (non-functioning) with High (Ki67 >2%) proliferation index / Pancreatic Endocrine Tumors (PETs) (non-functioning) without low (Ki67 <=2%) proliferation index | 1 | |
| Pancreatic Endocrine Tumors (PETs) (non-functioning) with liver metastasis / Purified islet cells | 1119 | | Capurso G et al (Jun-06) | 1119 | Transcriptomics | oligo Array;Commercial Array Plattform:U133A Affymetrix GeneChip;Commercial Array Plattform:U133B Affymetrix GeneChip; |
|
| Pancreatic Endocrine Tumors (PETs) (well-differentiated endocrine tumors carcinoma (WDEC)) / Pancreatic Acinar Cell Carcinoma (PACC) | 4 | |
| Pancreatic Endocrine Tumors (PETs) (well-differentiated endocrine tumors carcinoma (WDEC)), High(Ki67>2%) proliferation index/Pancreatic Endocrine Tumors (PETs)(well-differentiated endocrine tumors carcinoma (WDEC)) w/o low(Ki67<=2%) proliferation index | 1 | |
| Pancreatic intraepithelial neoplasia (PanIN) / Normal pancreas NP (bulk tissue) | 1 | |
| Pancreatic intraepithelial neoplasias (PanIN-1b) / Normal pancreas ND (microdissected normal ductal cells) | 42 | | Buchloz M et al (Oct-05) | 42 | Transcriptomics | oligo Array;Commercial Array Plattform: The Human Genome Oligo-Set-Version 2.0 (Operon, Germany); |
|
| Pancreatic intraepithelial neoplasias (PanIN-1B/2) / Normal pancreas ND (microdissected normal ductal cells) | 151 | |
| Pancreatic intraepithelial neoplasias (PanIN-2) / Normal pancreas ND (microdissected normal ductal cells) | 364 | | Buchloz M et al (Oct-05) | 364 | Transcriptomics | oligo Array;Commercial Array Plattform: The Human Genome Oligo-Set-Version 2.0 (Operon, Germany); |
|
| Pancreatic intraepithelial neoplasias (PanIN-3) / Normal pancreas ND (microdissected normal ductal cells) | 485 | | Buchloz M et al (Oct-05) | 485 | Transcriptomics | oligo Array;Commercial Array Plattform: The Human Genome Oligo-Set-Version 2.0 (Operon, Germany); |
|
| Pancreatic Juice from Chronic Pancreatitis / benign pancreatic diseases (benign cystic neoplasm) | 9 | |
| Pancreatic Juice from Pancreatic Adenocarcinomas (PDAC) / benign pancreatic diseases (benign cystic neoplasm) or patients undergoing evaluation of sphincter of oddi | 14 | |
| Pancreatic tumor central / peripheral (Xenograft from CL (orthotophic)) (microdissected) | 1079 | |